Eyeworld

FEB 2012

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/78719

Contents of this Issue

Navigation

Page 45 of 111

46 EW CATARACT New continued from page 45 the use of square-edged lenses, mak- ing the CC smaller than the optic of the lens and completely overlying it so that there are 360 degrees of over- lap of the anterior capsule on the optic, careful cortical cleaning and hydrodissection. He sees all of these as having become part-and-parcel of modern technique and helping to minimize the amount of PCO, which was known to clog the bag with a lot of floating debris. The main complication that Dr. Packer contends with after YAG is floaters. "There is really only one thing that I warn patients about, which is floaters—transient debris that is the remnants of the capsule floating around," he said. "I think that is the number one problem." These, he finds, usually dissipate on their own. More customary complications have not been an issue. "The classic complications cited for YAG are cystoid macular edema and retinal detachment," Dr. Packer said. "I've never seen either one in my career." He thinks these may have been a product of earlier-generation lasers that used more energy. Likewise, Dr. Packer doesn't see pressure spikes. "I don't treat with any drops and I don't see the patient back for 2 weeks," he said. "So I've never seen either of those." Michael S. Berlin, M.D., direc- tor, Glaucoma Institute of Beverly Hills, Calif., and professor of clinical ophthalmology, Jules Stein Eye Insti- tute, University of California, Los Angeles, credits the fact that PCO is being treated sooner and is much less dense with the declining amount of pressure spikes that he also sees. "We are releasing a lot less foreign material into the eye, so we're creating a lot less inflamma- tion," Dr. Berlin said. "By doing so, we're decreasing drastically the amount of post-op pressure spikes in the appropriate hands." One new complication that he does come up against is lens pitting. This he thinks may have to do with less consistent pulse-to-pulse out- puts of the newer lasers as well as 2 D targeting systems that don't ac- count for lens vignetting. "One must be very careful with settings with the current generation of YAG lasers and with the lenses used to make sure that we don't displace the focal points to create photodisruption more anterior than we anticipate causing lens pitting," Dr. Berlin said. Overall, Dr. Safran thinks that the reality has changed for patients who are now undergoing YAG cap- sulotomy. "A patient may go online and say, 'I don't want that laser be- cause I read about it, it can cause retinal detachment, macular edema, and glaucoma,'" he said. "The new reality is that those risks are pretty low, at least lower than they used to be." EW Editors' note: Dr. Berlin has financial interests with Alcon (Fort Worth, Texas), Merck (Whitehouse Station, N.J.), and Santen (Emeryville, Calif.). Dr. Safran has financial interests with Bausch + Lomb, Heidelberg Engineering (Carlsbad, Calif.), and Lenstec (St. Petersburg, Fla.). Drs. Packer and Trattler have no financial interests related to this article. Contact information Berlin: 310-855-1112, Berlin@ucla.edu Packer: 541-687-2110, mpacker@finemd.com Safran: 609-896-3931, safran12@comcast.net Trattler: 305-598-2020, wtrattler@earthlink.net February 2012

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - FEB 2012